BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 15215152)

  • 1. Mortality prediction in pulmonary Mycobacterium kansasii infection and human immunodeficiency virus.
    Marras TK; Morris A; Gonzalez LC; Daley CL
    Am J Respir Crit Care Med; 2004 Oct; 170(7):793-8. PubMed ID: 15215152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium kansasii infection in patients infected with the human immunodeficiency virus.
    Pintado V; Gómez-Mampaso E; Martín-Dávila P; Cobo J; Navas E; Quereda C; Fortún J; Guerrero A
    Eur J Clin Microbiol Infect Dis; 1999 Aug; 18(8):582-6. PubMed ID: 10517196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infections with Mycobacterium kansasii in the Academic Medical Center in Amsterdam: the changing clinical spectrum since the start of the HIV epidemic].
    van der Meer JT; Kerssemakers SP; van Steenwijk RP; Kuijper EJ
    Ned Tijdschr Geneeskd; 1998 Apr; 142(17):965-9. PubMed ID: 9623171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of HIV infection on Mycobacterium kansasii disease in South African gold miners.
    Corbett EL; Churchyard GJ; Hay M; Herselman P; Clayton T; Williams B; Hayes R; Mulder D; De Cock KM
    Am J Respir Crit Care Med; 1999 Jul; 160(1):10-4. PubMed ID: 10390373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1.
    Witzig RS; Fazal BA; Mera RM; Mushatt DM; Dejace PM; Greer DL; Hyslop NE
    Clin Infect Dis; 1995 Jul; 21(1):77-85. PubMed ID: 7578764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium kansasii in HIV patients: clarithromycin and antiretroviral effects.
    Tompkins JC; Witzig RS
    Int J Tuberc Lung Dis; 2007 Mar; 11(3):331-7. PubMed ID: 17352101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed analysis of the radiographic presentation of Mycobacterium kansasii lung disease in patients with HIV infection.
    Cattamanchi A; Nahid P; Marras TK; Gotway MB; Lee TJ; Gonzalez LC; Morris A; Webb WR; Osmond DH; Daley CL
    Chest; 2008 Apr; 133(4):875-80. PubMed ID: 18263685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners.
    Corbett EL; Blumberg L; Churchyard GJ; Moloi N; Mallory K; Clayton T; Williams BG; Chaisson RE; Hayes RJ; De Cock KM
    Am J Respir Crit Care Med; 1999 Jul; 160(1):15-21. PubMed ID: 10390374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium kansasii disease among patients infected with human immunodeficiency virus type 1: improved prognosis in the era of highly active antiretroviral therapy.
    Santin M; Alcaide F
    Int J Tuberc Lung Dis; 2003 Jul; 7(7):673-7. PubMed ID: 12870689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological, clinical, and prognostic differences between the diseases caused by Mycobacterium kansasii and Mycobacterium tuberculosis in patients infected with human immunodeficiency virus: a multicenter study.
    Canueto-Quintero J; Caballero-Granado FJ; Herrero-Romero M; Domínguez-Castellano A; Martín-Rico P; Verdú EV; Santamaría DS; Cerquera RC; Torres-Tortosa M;
    Clin Infect Dis; 2003 Aug; 37(4):584-90. PubMed ID: 12905144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nosocomial bacterial pneumonia in HIV-infected patients: risk factors for adverse outcome and implications for rational empiric antibiotic therapy.
    Franzetti F; Grassini A; Piazza M; Degl'innocenti M; Bandera A; Gazzola L; Marchetti G; Gori A
    Infection; 2006 Feb; 34(1):9-16. PubMed ID: 16501896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for mortality in patients with pulmonary infections with non-tuberculous mycobacteria: a retrospective cohort study.
    Gommans EP; Even P; Linssen CF; van Dessel H; van Haren E; de Vries GJ; Dingemans AM; Kotz D; Rohde GG
    Respir Med; 2015 Jan; 109(1):137-45. PubMed ID: 25464905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial community-acquired pneumonia in HIV-infected patients.
    Madeddu G; Laura Fiori M; Stella Mura M
    Curr Opin Pulm Med; 2010 May; 16(3):201-7. PubMed ID: 20154625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium kansasii pulmonary infection in patients with AIDS: spectrum of chest radiographic findings.
    Fishman JE; Schwartz DS; Sais GJ
    Radiology; 1997 Jul; 204(1):171-5. PubMed ID: 9205241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
    El Amari EB; Toutous-Trellu L; Gayet-Ageron A; Baumann M; Cathomas G; Steffen I; Erb P; Mueller NJ; Furrer H; Cavassini M; Vernazza P; Hirsch HH; Bernasconi E; Hirschel B;
    AIDS; 2008 May; 22(9):1019-28. PubMed ID: 18520345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London.
    Davies BS; Roberts CH; Kaul S; Klein JL; Milburn HJ
    Scand J Infect Dis; 2012 Nov; 44(11):815-9. PubMed ID: 23078529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium kansasii septicaemia in an AIDS patient complicated by acute respiratory distress syndrome and acute liver failure.
    Shaaban H; Layne T; Sensakovic JW; Boghossian J
    Int J STD AIDS; 2014 Feb; 25(2):152-4. PubMed ID: 23970643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
    ter Horst R; Collin SM; Ritmeijer K; Bogale A; Davidson RN
    Clin Infect Dis; 2008 Jun; 46(11):1702-9. PubMed ID: 18419422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.